Teva Pharmaceutical Industries

Results: 58



#Item
1January 8, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion Immuno­Oncology Deal In yet

January 8, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion Immuno­Oncology Deal In yet

Add to Reading List

Source URL: www.dcat.org

Language: English - Date: 2016-01-11 11:16:23
2December 4, 2015 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum 1. Teva, Takeda Form Generics Joint Venture in Japan Teva Pharmaceu

December 4, 2015 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum 1. Teva, Takeda Form Generics Joint Venture in Japan Teva Pharmaceu

Add to Reading List

Source URL: www.dcat.org

Language: English - Date: 2016-01-05 08:55:58
3Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016

Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2016-07-22 09:17:34
4LEGAL NOTICE and TERMS OF USE Teva Respiratory, LLC (“Teva Respiratory”) maintains the sites www.ProAirHFA.com and www.MyProAir.com, and www.ProAir.com (the

LEGAL NOTICE and TERMS OF USE Teva Respiratory, LLC (“Teva Respiratory”) maintains the sites www.ProAirHFA.com and www.MyProAir.com, and www.ProAir.com (the "sites") for your personal information, education, and comm

Add to Reading List

Source URL: www.proair.com

Language: English - Date: 2016-06-17 15:42:12
5Statement of the Federal Trade Commission In the Matter of Teva Pharmaceuticals Industries Ltd. and Allergan plc

Statement of the Federal Trade Commission In the Matter of Teva Pharmaceuticals Industries Ltd. and Allergan plc

Add to Reading List

Source URL: www.ftc.gov

Language: English
6REGISTER FOR APPROVED HUMAN MEDICINES JUNE 2016 UPDATE GENERIC NAME FORM DEXTROSE MONOHYDRATE OR ANHYDROUS INFUSIONS

REGISTER FOR APPROVED HUMAN MEDICINES JUNE 2016 UPDATE GENERIC NAME FORM DEXTROSE MONOHYDRATE OR ANHYDROUS INFUSIONS

Add to Reading List

Source URL: www.mcaz.co.zw

Language: English - Date: 2016-07-04 06:21:42
7April 8, Pfizer and Allergan Terminate $160 Billion Merger; New US Treasury Department Action at Play Pfizer and Allergan have called off their proposed $160 billion merger citing the US Depart

April 8, Pfizer and Allergan Terminate $160 Billion Merger; New US Treasury Department Action at Play Pfizer and Allergan have called off their proposed $160 billion merger citing the US Depart

Add to Reading List

Source URL: www.dcat.org

Language: English - Date: 2016-04-08 15:57:35
8imap AN IMAP INDUSTRY REPORT GLOBAL M&A REPORT

imap AN IMAP INDUSTRY REPORT GLOBAL M&A REPORT

Add to Reading List

Source URL: www.kurmannpartners.com

Language: English - Date: 2016-03-16 06:35:36
9TEVA PHARMACEUTICAL INDUSTRIES LIMITED Notice of Special Meeting of Shareholders October 1, 2015 Dear Shareholder,

TEVA PHARMACEUTICAL INDUSTRIES LIMITED Notice of Special Meeting of Shareholders October 1, 2015 Dear Shareholder,

Add to Reading List

Source URL: tevapharm.com

Language: English
    104 strategic archetypes for pharma companies DEAL DRIVERS DEALS INPipeline deals

    4 strategic archetypes for pharma companies DEAL DRIVERS DEALS INPipeline deals

    Add to Reading List

    Source URL: www.kurmannpartners.com

    Language: English - Date: 2016-03-16 06:29:23